• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETBF3616C145E
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code Injury (2348)
Date of Event 11/12/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant ii stent graft system was implanted in a patient for the endovascular treatment of a 50mm diameter abdominal aortic aneurysm with short neck indication.It was also reported that endoanchors were implanted on an unknown date post the index procedure.It was reported that approximately four years post-index procedure a follow up ct revealed a moderate type ia endoleak and it was reported the aneurysm was up to 2mm below the level of the lowest renal artery.Per the physician the cause of the event was anatomy related due to disease progression with neck dilation.No additional clinical sequelae were reported and the patient will be monitored.
 
Additional Manufacturer Narrative
The reported proximal type i endoleak was confirmed.However, the exact cause of the type ia endoleak leading to the aaa enlargement could not be determined from the films provided.The anatomy at implant is unknown, and earlier follow-up films were not provided for comparison.Review of a post-implant ct-3d film report from 4 years post-implant (b)(6) 2018) revealed that the aaa diameter measured 81mm and there was a proximal type i endoleak.The bifurcate was positioned just below the renal arteries within the short and conical-shaped neck, and multiple endoanchors appeared to have been implanted into the bifurcate proximal margin.The neck diameter just below the renals measured 28mm, 15mm below the renals tapered out to 36mm in diameter, and the infrarenal neck contained thrombus.The bifurcate ipsi limb was seen extending distally into the left common iliac, and the contra limb was positioned down into the right common iliac artery.The devices appeared patent and no other obvious issues were observed.It is possible that disease progression, leading to the short and dilatated proximal neck, may have contributed to the proximal type i endoleak.Additional information received; the endoanchors were implanted at approximately the same time as the endurant.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key8084387
Report Number2953200-2018-01587
Device Sequence Number2165689
Product Code MIH
UDI-Device Identifier00613994991034
UDI-Public00613994991034
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/03/2016
Device Model NumberETBF3616C145E
Device Catalogue NumberETBF3616C145E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/15/2018
Initial Date Received by Manufacturer 11/14/2018
Supplement Date Received by Manufacturer11/27/2018
Initial Report FDA Received Date11/19/2018
Supplement Report FDA Received Date12/18/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age85 YR
-
-